Regenxbio (RGNX) EBT Margin Growth (1y) (2015 - 2025)
Regenxbio (RGNX) EBT Margin Growth (1y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Regenxbio |
315.11 Mn |
85.04 Mn |
- |
2,027.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
2,027.00 |
| Sep 30, 2025 |
3,801.00 |
| Jun 30, 2025 |
-9,410.00 |
| Mar 31, 2025 |
41,243.00 |
| Dec 31, 2024 |
4,180.00 |
| Sep 30, 2024 |
-3,243.00 |
| Jun 30, 2024 |
12,292.00 |
| Mar 31, 2024 |
-5,723.00 |
| Dec 31, 2023 |
-98,650.00 |
| Sep 30, 2023 |
7,074.00 |
| Jun 30, 2023 |
-15,190.00 |
| Mar 31, 2023 |
-289.00 |
| Dec 31, 2022 |
62,591.00 |
| Sep 30, 2022 |
-9,492.00 |
| Jun 30, 2022 |
5,276.00 |
| Mar 31, 2022 |
-8,001.00 |
| Dec 31, 2021 |
-22,814.00 |
| Sep 30, 2021 |
-19,868.00 |
| Jun 30, 2021 |
-5,476.00 |
| Mar 31, 2021 |
-3,857.00 |
